Hilltop Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,515
Closed -$931K 774
2025
Q4
$931K Buy
+5,515
New +$896K 0.06% 351
2021
Q4
Sell
-6,913
Closed -$1.12M 616
2021
Q3
$1.12M Sell
6,913
-1,651
-19% -$278K 0.12% 170
2021
Q2
$1.4M Buy
8,564
+6,873
+406% +$1.06M 0.16% 132
2021
Q1
$255K Buy
+1,691
New +$269K 0.03% 454
2020
Q3
Sell
-10,982
Closed -$1.5M 435
2020
Q2
$1.5M Buy
+10,982
New +$1.4M 0.28% 86

Other funds holding IBB

Hilltop Holdings's IBB Position: Q1 2026 in Review

Hilltop Holdings sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 5,515 shares — an estimated $931K sold.

Hilltop Holdings first reported a position in IBB in Q2 2020 and held it in 5 quarters. The position peaked at $1.5M in Q2 2020. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Hilltop Holdings reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Hilltop Holdings sold 5,515 iShares Biotechnology ETF shares in Q1 2026, an estimated $931K.
  • Hilltop Holdings first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 5 quarters.
  • Hilltop Holdings's iShares Biotechnology ETF position peaked at $1.5M in Q2 2020.
  • 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.